Anzeige
❌
Mehr »
Samstag, 21.11.2026 - Börsentäglich über 12.000 News
Zufall oder Strategie? Copper One zündet die nächste Stufe seiner Kupfer-Offensive!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrMSD and Isomorphic join forces to develop oncology drugs
FrNovartis CEO leans on surge of pipeline readouts to quell growth fears
FrSanofi rumoured to be eyeing high-profile Insmed takeover
DoRecursion CEO details novel Phase III endpoint for rare disease drug
DoGeopolitical pressures and greater buyer selectivity hamper M&A deal closure rates
DoEllipses Pharma plots London listing that could end British biotech IPO drought
DoAbbVie and Disco ink $2.5bn pact for next-generation cancer bispecifics
DoPfizer inks $2.6bn autoimmune deal with China's Starna for CAR-T therapies
DoBridging gaps in rare disease drug access requires strategic rethink
DoGenomics, Vertex extend drug discovery alliance in $220m deal
DoFDA approves Regeneron's Livsayis for generalised myasthenia gravis
MiEuropean capital markets require efforts to attract biotech listings
MiGSK's $10.6bn Nuvalent bet pays off with second lung cancer drug approval
MiIsomorphic Labs raises $5bn to advance drug pipeline
MiRevolution Medicines' Rasonque gains EC authorisation for pancreatic cancer
DiEli Lilly inks cancer pact worth up to $5.9bn with Stipple Bio
DiPfizer CEO: 'China will be my major competition by 2030'
DiSeawolf Therapeutics and Sanofi agree $1.2bn drug deal
DiUK biotech sector calls on government to support sector's growth on home soil
DiLilly agrees to acquire Calytrix Bio for $1.5bn
MoJ&J outlays up to $3.3bn to buy ophthalmology specialist Ollin Biosciences
MoRevMed CEO on tackling "complex" launch for wonder pancreatic drug
MoFlagship Pioneering expands to UK with £100m AI-native lab
MoSofinnova Partners backs European life sciences sector with €725M raise
MoAstraZeneca secures FDA approval for Imfinzi combo in MIBC